BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22544733)

  • 1. A nomogram for individualized estimation of survival among patients with brain metastasis.
    Barnholtz-Sloan JS; Yu C; Sloan AE; Vengoechea J; Wang M; Dignam JJ; Vogelbaum MA; Sperduto PW; Mehta MP; Machtay M; Kattan MW
    Neuro Oncol; 2012 Jul; 14(7):910-8. PubMed ID: 22544733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
    Gittleman H; Lim D; Kattan MW; Chakravarti A; Gilbert MR; Lassman AB; Lo SS; Machtay M; Sloan AE; Sulman EP; Tian D; Vogelbaum MA; Wang TJC; Penas-Prado M; Youssef E; Blumenthal DT; Zhang P; Mehta MP; Barnholtz-Sloan JS
    Neuro Oncol; 2017 May; 19(5):669-677. PubMed ID: 28453749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer.
    Pietrantonio F; Aprile G; Rimassa L; Franco P; Lonardi S; Cremolini C; Biondani P; Sbicego EL; Pasqualetti F; Tomasello G; Niger M; Casagrande M; Ghidini M; Muni R; Montrone S; Bergamo F; Berenato R; Fontanella C; Bozzarelli S; Moretto R; Battaglin F; Di Bartolomeo M; de Braud F; Miceli R
    Radiother Oncol; 2015 Nov; 117(2):315-21. PubMed ID: 26347495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model outperforming RPA and DS-GPA scores for individualized survival prediction of patients following whole brain irradiation for brain metastasis.
    Marchand-Crety C; Riverain J; Drouet Y; Felici F; Jeandidier CL; Thariat J; Servagi-Vernat S
    Cancer Radiother; 2021 Jul; 25(5):447-456. PubMed ID: 33678525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery.
    Kano H; Morales-Restrepo A; Iyer A; Weiner GM; Mousavi SH; Kirkwood JM; Tarhini AA; Flickinger JC; Lunsford LD
    J Neurosurg; 2018 Jan; 128(1):14-22. PubMed ID: 28106495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone.
    Likhacheva A; Pinnix CC; Parikh N; Allen PK; Guha-Thakurta N; McAleer M; Sulman EP; Mahajan A; Shiu A; Luo D; Chiu M; Brown PD; Prabhu SS; Chang EL
    J Neurosurg; 2012 Dec; 117 Suppl(0):38-44. PubMed ID: 23205787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
    J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?
    Nieder C; Nestle U; Motaref B; Walter K; Niewald M; Schnabel K
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):297-302. PubMed ID: 10661335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
    Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
    J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models.
    Marko NF; Xu Z; Gao T; Kattan MW; Weil RJ
    Cancer; 2012 Aug; 118(15):3749-57. PubMed ID: 22180078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
    Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
    BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing different brain metastasis grading systems in stereotactic radiosurgery: Radiation Therapy Oncology Group's RPA, SIR, BSBM, GPA, and modified RPA.
    Serizawa T; Higuchi Y; Nagano O; Hirai T; Ono J; Saeki N; Miyakawa A
    J Neurosurg; 2012 Dec; 117 Suppl():31-7. PubMed ID: 23205786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robustness of the neurological prognostic score in brain metastasis patients treated with Gamma Knife radiosurgery.
    Serizawa T; Higuchi Y; Nagano O; Matsuda S; Aoyagi K; Ono J; Saeki N; Iwadate Y; Hirai T; Takemoto S; Shibamoto Y
    J Neurosurg; 2017 Nov; 127(5):1000-1006. PubMed ID: 27911235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases.
    Videtic GM; Adelstein DJ; Mekhail TM; Rice TW; Stevens GH; Lee SY; Suh JH
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):240-3. PubMed ID: 17056192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.
    Sperduto PW; Kased N; Roberge D; Xu Z; Shanley R; Luo X; Sneed PK; Chao ST; Weil RJ; Suh J; Bhatt A; Jensen AW; Brown PD; Shih HA; Kirkpatrick J; Gaspar LE; Fiveash JB; Chiang V; Knisely JP; Sperduto CM; Lin N; Mehta M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2111-7. PubMed ID: 21497451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.
    Gaspar L; Scott C; Rotman M; Asbell S; Phillips T; Wasserman T; McKenna WG; Byhardt R
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):745-51. PubMed ID: 9128946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.
    Subbiah IM; Lei X; Weinberg JS; Sulman EP; Chavez-MacGregor M; Tripathy D; Gupta R; Varma A; Chouhan J; Guevarra RP; Valero V; Gilbert MR; Gonzalez-Angulo AM
    J Clin Oncol; 2015 Jul; 33(20):2239-45. PubMed ID: 25987700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
    Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
    BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.